Dynavax Technologies
DVAX
#5017
Rank
ยฃ1.38 B
Marketcap
ยฃ11.79
Share price
0.00%
Change (1 day)
10.71%
Change (1 year)

Dynavax Technologies (DVAX) - Total debt

Total debt on the balance sheet as of September 2025 : ยฃ0.21 Billion

According to Dynavax Technologies 's latest financial reports the company's total debt is ยฃ0.21 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Dynavax Technologies - Total debt on balance sheet (from 2009 to 2025)

Total debt by year

Year Total debt Change
2024-12-31ยฃ0.20 B0.53%
2023-12-31ยฃ0.20 B-5.44%
2022-12-31ยฃ0.21 B11.85%
2021-12-31ยฃ0.19 B19.31%
2020-12-31ยฃ0.15 B-3.17%
2019-12-31ยฃ0.16 B107.71%
2018-12-31ยฃ79.46 M
2014-12-31ยฃ6.13 M
2012-12-31N/A-100%
2011-12-31ยฃ8.24 M7.98%
2010-12-31ยฃ7.63 M-0.25%
2009-12-31ยฃ7.65 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
ยฃ48.06 B 22,071.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ43.58 B 20,004.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ6.35 B 2,831.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ19.96 B 9,108.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ41.00 B 18,812.79%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ24.52 B 11,210.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ23.91 B 10,929.91%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
ยฃ30.96 M-85.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ12.83 B 5,820.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel